FDA Considers Psychedelic MDMA Therapy For Post-Traumatic Stress Disorder

A panel of advisors to the FDA on Tuesday will weigh whether the agency should approve the use of MDMA, also known as ecstasy, to treat post-traumatic stress disorder. CNN’s Chief Medical Correspondent Sanjay Gupta reports.